**OpenAI** is reportedly testing a new subscription model named "ChatGPT for Science." References to this feature have been observed within the web build of **ChatGPT**, suggesting an imminent expansion of its offerings.  Currently, **OpenAI** provides **ChatGPT** for personal use, **Teams**, and dedicated business/enterprise solutions. While the personal version is broadly accessible, **Teams** requires a company domain and at least three users, and the business iteration is exclusive to legal entities. It is anticipated that "ChatGPT for Science" will come with similar access restrictions, likely catering only to verified academic or research institutions. ## Optimizing ChatGPT for Scientific Research This isn't **OpenAI**'s first venture into optimizing its AI models for scientific applications. The company recently unveiled **GPT-Rosalind**, a specialized model built on the advanced **GPT-5.5** architecture. **GPT-Rosalind** is not merely a reskinned version of **ChatGPT** but a purpose-built tool designed for enterprise-scale life sciences research. Its deployment operates under a "trusted-access deployment structure," limiting its availability to eligible organizations, such as major pharmaceutical firms like **Novo Nordisk** and verified research institutions engaged in legitimate, public-benefit scientific research. This specialized model requires enterprise-grade security and robust safety governance, surpassing the stringent requirements of **ChatGPT Enterprise**. It is plausible that "ChatGPT for Science" aims to democratize some of these advanced capabilities, making them accessible to a broader range of institutions rather than confining them to select partners. This would imply that "ChatGPT for Science" will possess specialized grounding in scientific discoveries and research topics, offering a more nuanced and accurate experience compared to general-purpose subscriptions. While an official launch date for "ChatGPT for Science" remains unconfirmed, active testing on the web suggests an announcement could be weeks away, promising a significant development for the scientific community leveraging AI.